Role of Estrogen on Skeletal Outcomes in FHA

NCT07010146 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Bone Strength
Bone Density
FHA (Functional Hypothalamic Amenorrhea)

Interventions

DRUG: transdermal 17β-E2 with cyclic progestin
DRUG: oral 17β-E2 with cyclic progestin
DRUG: transdermal EE+LNG

Sponsor

University of Virginia

Collaborators

[object Object]